Your browser doesn't support javascript.
loading
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Oaknin, Ana; Tinker, Anna V; Gilbert, Lucy; Samouëlian, Vanessa; Mathews, Cara; Brown, Jubilee; Barretina-Ginesta, Maria-Pilar; Moreno, Victor; Gravina, Adriano; Abdeddaim, Cyril; Banerjee, Susana; Guo, Wei; Danaee, Hadi; Im, Ellie; Sabatier, Renaud.
Afiliação
  • Oaknin A; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Tinker AV; Division of Medical Oncology, BC Cancer-Vancouver, Vancouver, British Columbia, Canada.
  • Gilbert L; Division of Gynecologic Oncology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Samouëlian V; Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Mathews C; Women and Infants' Program in Women's Oncology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island.
  • Brown J; Levine Cancer Institute, Division of Gynecologic Oncology, Atrium Health, Charlotte, North Carolina.
  • Barretina-Ginesta MP; Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain.
  • Moreno V; Girona Biomedical Research Institute, Department of Medical Sciences, Medical School University of Girona, Girona, Spain.
  • Gravina A; START Madrid-Fundación Jiménez Díaz, Hospital Fundación Jiménez Díaz, Madrid, Spain.
  • Abdeddaim C; Struttura Complessa Sperimentazioni Cliniche, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Pascale, Naples, Italy.
  • Banerjee S; Department of Gynecological Oncology, Centre de Lutte Contre le Cancer-Centre Oscar Lambret, Lille, France.
  • Guo W; Gynaecology Unit, The Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Danaee H; Oncology Development Bioststats Unit, GlaxoSmithKline, Waltham, Massachusetts.
  • Im E; Experimental Medicine Unit, GlaxoSmithKline, Waltham, Massachusetts.
  • Sabatier R; Oncology Clinical Development-Immuno-Oncology Clinical Unit, GlaxoSmithKline, Waltham, Massachusetts.
Future Oncol ; 17(29): 3781-3785, 2021 Oct 01.
Article em En | MEDLINE | ID: mdl-34427115
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article